From private equity giants like TPG Capital to the investment arms of big pharmaceutical firms like Novo Nordisk A/S, investors have bet a combined $3.7 billion on Indian health-related startups since 2022, according to data aggregator Tracxn Technologies Ltd. This is half of the $7.4 billion that health tech-focused firms have raised across the Asia Pacific region, according to Tracxn.